Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor

By Takahashi H.   Sato N.   Shibata A.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 339-348

Elsevier

Access to resources Recommend Favorite

BINDING OF TISSUE FACTOR PATHWAY INHIBITOR TO CULTURED ENDOTHELIAL CELLS-INFLUENCE OF GLYCOSAMINOGLYCANS - VII: Additional pathway initiating blood coagulation

By Iversen N.   Sandset P.M.   Abildgaard U.   Torjesen P.A.  

Thrombosis Research, Vol. 84, Iss. 4, 1996-11 ,pp. : 267-278

Elsevier

Access to resources Recommend Favorite

Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor

By Bladbjerg E.M.  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3235-3241

Oxford University Press

Access to resources Recommend Favorite

Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases

By He M.   Wen Z.   He X.   Xiong S.   Liu F.   Xu J.   Li J.   Xie Q.   Jian Z.   Chen F.   Xiao B.   Pu X.   He S.  

Thrombosis Research, Vol. 107, Iss. 5, 2002-09 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

By Hansen J.-B.   Naalsund T.   Sandset P.M.   Svensson B.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 413-417

Elsevier

Access to resources Recommend Favorite